48 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Alpltm1Jlm/Alpltm1Jlm Spp1tm1Rit/Spp1tm1Rit involves: 129S1/SvImJ * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6	abnormal dentin morphology	J:233260
	abnormal tooth root development	J:233260
Alpltm1Jlm/Alpltm1Jlm Spp1tm1Rit/Spp1tm1Rit involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6	abnormal osteoblast physiology	J:128077
	decreased body weight	J:128077
	decreased bone mineralization	J:128077
	increased bone mineral density of lumbar vertebrae	J:128077
	increased bone mineral density of presacral vertebrae	J:128077
	increased bone trabecula number	J:128077
	postnatal lethality, complete penetrance	J:128077
Apoetm1Unc/Apoetm1Unc Spp1tm1Blh/Spp1+ involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J	atherosclerotic lesions	J:86531
Apoetm1Unc/Apoetm1Unc Spp1tm1Blh/Spp1tm1Blh involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J	abnormal macrophage physiology	J:86531
	decreased susceptibility to atherosclerosis	J:86531
	decreased susceptibility to induced aneurysm formation	J:86531
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1+ involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6	decreased susceptibility to atherosclerosis	J:103051
	increased circulating cholesterol level	J:103051
	increased circulating triglyceride level	J:103051
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1tm1Rit involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6	calcified artery	J:103051
	decreased susceptibility to atherosclerosis	J:103051
	increased circulating cholesterol level	J:103051
	increased circulating triglyceride level	J:103051
Aprttm1Jat/Aprttm1Jat Spp1tm1Rit/Spp1tm1Rit involves: 129S2/SvPas * 129S7/SvEvBrd	abnormal body weight	J:114314
	abnormal kidney morphology	J:114314
	abnormal urine nucleoside level	J:114314
	decreased body weight	J:114314
	postnatal lethality	J:114314
Dmdmdx/Dmdmdx Spp1tm1Blh/Spp1tm1Blh involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn	abnormal muscle physiology	J:150572
	abnormal physical strength	J:150572
	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Dmdmdx/Y Spp1tm1Blh/Spp1tm1Blh involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn	abnormal muscle physiology	J:150572
	abnormal physical strength	J:150572
	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Faslpr/Faslpr Spp1tm1Rit/Spp1tm1Rit involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp	enlarged spleen	J:73396
	increased anti-double stranded DNA antibody level	J:73396
	increased anti-single stranded DNA antibody level	J:73396
	increased IgA level	J:73396
	increased IgG1 level	J:73396
	increased IgG2a level	J:73396
	increased IgG2b level	J:73396
	increased IgG3 level	J:73396
	increased IgM level	J:73396
	kidney inflammation	J:73396
	lymph node hyperplasia	J:73396
Mgptm1Kry/Mgp+ Spp1tm1Blh/Spp1tm1Blh involves: Black Swiss * C57BL/6J	calcified artery	J:79746
	internal hemorrhage	J:79746
	premature death	J:79746
Mgptm1Kry/Mgptm1Kry Spp1tm1Blh/Spp1+ involves: Black Swiss * C57BL/6J	calcified artery	J:79746
	internal hemorrhage	J:79746
	premature death	J:79746
Mgptm1Kry/Mgptm1Kry Spp1tm1Blh/Spp1tm1Blh involves: Black Swiss * C57BL/6J	abnormal aorta morphology	J:79746
	aneurysm	J:79746
	calcified artery	J:79746
	internal hemorrhage	J:79746
	premature death	J:79746
Spp1tm1Blh/Spp1tm1Blh Umodtm1Xrw/Umodtm1Xrw 129S/SvEv-Spp1tm1Blh Umodtm1Xrw	crystalluria	J:127526
	dilated kidney collecting duct	J:127526
	increased urine phosphate level	J:127526
	increased urine uric acid level	J:127526
	nephrocalcinosis	J:127526
	renal fibrosis	J:127526